Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal JunctionJin Li, Hao Yu, Shukui Qin et al.|Journal of Clinical Oncology|2016Cited by 1k
Safety, anti-tumour activity, and pharmacokinetics of fixed-dose SHR-1210, an anti-PD-1 antibody in advanced solid tumours: a dose-escalation, phase 1 studyHongnan Mo, Binghe Xu, Dawei Wu et al.|British Journal of Cancer|2018Cited by 156